Here are the top stories from the last week:

APhA wins legislative victory allowing pharmacists to prescribe Buprenorphine
‍The American Pharmacists Association (APhA) has achieved a policy victory by expanding pharmacists' authority to treat opioid use disorder. The new legislation allows pharmacists to prescribe buprenorphine, a key medication for opioid use disorder, after completing an 8-hour training program.
‍Read article »

CGMs That Measure Alternative Biofluids Show Potential in Diabetes Care
Continuous glucose monitoring (CGM) via interstitial fluid, sweat, and saliva are less invasive than prior methods.
Read article »

Low-Dose Cannabinoids Show Potential to Restore Serotonin Levels and Reduce Inflammation in HIV, Study Finds
Research reveals low-dose cannabinoids, like THC, may enhance serotonin levels and combat chronic inflammation in HIV patients, offering new treatment possibilities.
Read article »

NCPA urges Congress to pass Crapo-Wyden PBM Reforms
‍The National Community Pharmacists Association (NCPA) is urging Congress to pass the PBM Price Transparency and Accountability Act, which aims to hold pharmacy benefit managers accountable for raising drug prices and expanding pharmacy deserts. The legislation has wide bipartisan support.
‍Read article »

New Point-of-Care Test Offers Fast, Accurate Pertussis Diagnosis
A new rapid test for pertussis enables quick diagnosis in as little as 15 minutes, addressing rising whooping cough cases.
Read article »

Amycretin Shows Significant Weight Loss, HbA1c Reductions in Type 2 Diabetes
In a phase 2 trial, the unimolecular agonist of GLP-1 and amylin induced major reductions in weight loss and hemoglobin A1c in patients with type 2 diabetes.
Read article »

Celltrion receives FDA nod for Xolair biosimilar's new dosing option
‍Celltrion received FDA approval for a new dosing option for Omlyclo, a biosimilar to Xolair, addressing the diverse needs of patients with allergic and inflammatory conditions. The new dosing option aims to reduce the number of required injections and ease treatment burden for patients.
‍Read article »

‍

‍